Select Page

Infinium Global Research has added a new report on Conjugate Vaccine Market. The report covers the analysis of global as well as regional markets of the conjugate vaccine. Moreover, the report gives insights into the factors that affect the global as well as the regional performance of the market in the short run and in the long run. According to the report, the global conjugate vaccine market is projected to grow at a CAGR of 9.5% over the forecast period of 2019-2025.

For More Details Get FREE Sample Pages of this Research Report@

The main role of the vaccine is to prevent diseases by activating an immune response to an antigen. Conjugate vaccine is made to overcome the short-term immune response. Conjugate vaccine is the combination of weak antigen with a strong antigen. The weak antigen is combined as a carrier, it makes a stronger immune response to the weak antigen.

Conjugate Vaccine Market: Drivers, Restraints, and Opportunities

The increasing number of viral infections globally is one of the major drivers for the growth of the conjugate vaccine market. According to WHO prevalence of viral diseases such as influenza, childhood viral pneumonia, and hepatitis has increased significantly in the last decade. Increasing the antigenicity of viral pathogens is also supporting the growth of the conjugate vaccine market.

Moreover, rising government initiatives for the vaccination program is another factor fuelling the conjugate vaccine market. Most of the developing and developed countries have applied stringent regulations for the vaccination to control the prevalence of viral diseases worldwide that in turn is contributing to the growth of the conjugate vaccine market. On the other hand, the high cost associated with the vaccines and lack of government centers for vaccination in developing countries can hamper the growth of the market. However, increasing awareness about viral diseases globally can provide better opportunities for the market in the forecast period.

North America Dominates the Conjugate Vaccine Market

Geographically, the conjugate Vaccine market is segmented by North America, Europe, Asia Pacific, and RoW. North America dominates the Conjugate Vaccine market and expected keep to its dominance over the forecast period. The presence of major biotech companies, increasing research and development activities for effective vaccine production and growing awareness about immunization programs among people are some of the factors contributing to the growth of the market in this region. Europe is anticipated to register healthy growth in the forecast period. Whereas, Asia-Pacific is expected to grow with a lucrative rate in the forecast period. Growing prevalence of the viral disease, initiatives by major pharma players in this region for vaccine production, and rising government initiatives for immunization programs have expected to boost the Conjugate Vaccine market in this region.

Conjugate Vaccine Market: Segmentation

The report on the global conjugate vaccine market covers segments such as type, disease indication, pathogen type, and end-user. On the basis of type, the sub-markets include monovalent conjugate vaccines and multivalent conjugate vaccines. On the basis of disease indication, the sub-markets include influenza, diphtheria and pertussis (DTP), pneumococcal, meningococcal, and other disease indication. On the basis of pathogen type, the sub-markets include viral conjugate vaccine, bacterial conjugate vaccine, and combination (viral and bacterial) conjugate vaccine. On the basis of end-user, the sub-markets include adults conjugate vaccine and pediatrics conjugate vaccine.

Conjugate Vaccine Market: Competitive Landscape

The report provides profiles of the companies in the market such as Serum Institute of India, Novartis AG, Nuron Biotech Inc., Sanofi Pasteur, Bharat Biotech, Pfizer, Inc., Biological E. Ltd, Merck and Company, CSL Limited, GlaxoSmithKline, plc., and Other companies.

Browse Detailed TOC and Description of this Exclusive Report@

Reasons to Buy this Report:

  • Comprehensive analysis of global as well as regional markets of the Conjugate Vaccine.
  • Complete coverage of all the product type and application segments to analyze the trends, developments, and forecast of market size up to 2025.
  • Comprehensive analysis of the companies operating in this market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and the latest developments of the company.
  • Infinium Global Research- Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.